Basilea Pharmaceutica (BSLN.SW) Appoints New Chief Financial Officer
11/4/2013 9:37:27 AM
Basilea Pharmaceutica Ltd. (SIX: BSLN)
announced today the promotion of Mr. Donato Spota to Chief Financial Officer of
the Company, effective today. As a member of the management committee, he will
be responsible for finance, information technology, and internal services. Mr.
Spota has served as Global Head of Finance and Services since February 2013.
Prior to this position, Mr. Spota acted as Head of Basilea's Global Controlling
Help employers find you! Check out all the jobs and post your resume.